SORT BY

FILTER BY

also on other fortune lists

company facts

g500 stats

Global 500

Bloomberg via Getty Images

169

Roche Group

RHHBY

Switzerland

Looking for leads, investment insights, or competitive intelligence?

CEO

Severin Schwan

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

Basel, Switzerland

Years on Global 500 List

24

Employees

93,734

Figures prepared in accordance with International Accounting Standards.
Key Financials (Last Fiscal Year)
($ Millions)% change
Revenues ($M)$56,6346.0%
Profits ($M)$8,770.6-9.8%
Assets ($M)$78,699
Total Stockholder Equity ($M)$27,139
Profit Ratios
Profit as % of Revenues15.5%
Profits as % of Assets11.1%
Profits as % of Stockholder Equity32.3%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Roche Group

The FDA Approved the First Big New Flu Drug in Almost 20 Years—And Is Approaching a Drug Approval Record

Shionogi and Genentech's Xofluza may treat certain people's flu symptoms faster.

Read More →
These Are the Health Care Companies Poised for Explosive Growth

From genetic testing giants to copycat drug manufacturers, here are the global companies set to make a mark on medicine.

Read More →
Japan Just Approved a New Drug That Can Kill the Flu Virus In Just One Day

But Shionogi's Xofluza likely won't be available in the U.S. till at least 2019.

Read More →
Why Drug Giant Roche's $1.9 Billion Deal to Buy Data Startup Flatiron Health Matters

Flatiron is connected with hundreds of cancer treatment centers—and its data collection could spur new drugs.

Read More →